Literature DB >> 20865476

Gut microbiota and related diseases: clinical features.

Vincenzo Stanghellini1, Giovanni Barbara, Cesare Cremon, Rosanna Cogliandro, Alexandra Antonucci, Veronica Gabusi, Chiara Frisoni, Roberto De Giorgio, Valentina Grasso, Mauro Serra, Roberto Corinaldesi.   

Abstract

Intestinal microbiota is essential for gut homeostasis. Specifically, the microorganisms inhabiting the gut lumen interact with the intestinal immune system, supply key nutrients for the major components of the gut wall, and modulate energy metabolism. Host-microbiome interactions can be either beneficial or deleterious, driving gastrointestinal lymphoid tissue activities and shaping gut wall structures. This overview briefly focuses on the potential role played by abnormalities in gut microbiota and relative responses of the gastrointestinal tract in the determination of important pathological conditions such as the irritable bowel syndrome, inflammatory bowel diseases and colorectal cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20865476     DOI: 10.1007/s11739-010-0451-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  48 in total

Review 1.  Relevance of serologic studies in inflammatory bowel disease.

Authors:  Gwenola Vernier; Boualem Sendid; Daniel Poulain; Jean-Frédéric Colombel
Journal:  Curr Gastroenterol Rep       Date:  2004-12

2.  Effects of high risk and low risk diets for colon carcinogenesis on fecal microflora and steroids in man.

Authors:  B S Reddy; J H Weisburger; E L Wynder
Journal:  J Nutr       Date:  1975-07       Impact factor: 4.798

3.  The fecal microbial population in the irritable bowel syndrome.

Authors:  A Balsari; A Ceccarelli; F Dubini; E Fesce; G Poli
Journal:  Microbiologica       Date:  1982-07

4.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

5.  Role for protease activity in visceral pain in irritable bowel syndrome.

Authors:  Nicolas Cenac; Christopher N Andrews; Marinella Holzhausen; Kevin Chapman; Graeme Cottrell; Patricia Andrade-Gordon; Martin Steinhoff; Giovanni Barbara; Paul Beck; Nigel W Bunnett; Keith A Sharkey; Jose Geraldo P Ferraz; Eldon Shaffer; Nathalie Vergnolle
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

Review 6.  Flag in the crossroads: flagellin modulates innate and adaptive immunity.

Authors:  Andrew T Gewirtz
Journal:  Curr Opin Gastroenterol       Date:  2006-01       Impact factor: 3.287

7.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

8.  Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria.

Authors:  Johanna Maukonen; Reetta Satokari; Jaana Mättö; Hans Söderlund; Tiina Mattila-Sandholm; Maria Saarela
Journal:  J Med Microbiol       Date:  2006-05       Impact factor: 2.472

9.  CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease.

Authors:  Nicolas Barnich; Frédéric A Carvalho; Anne-Lise Glasser; Claude Darcha; Peter Jantscheff; Matthieu Allez; Harald Peeters; Gilles Bommelaer; Pierre Desreumaux; Jean-Frédéric Colombel; Arlette Darfeuille-Michaud
Journal:  J Clin Invest       Date:  2007-05-24       Impact factor: 14.808

10.  Alternative pathways for hydrogen disposal during fermentation in the human colon.

Authors:  G R Gibson; J H Cummings; G T Macfarlane; C Allison; I Segal; H H Vorster; A R Walker
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

View more
  6 in total

Review 1.  The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis.

Authors:  Margaret Cho; Janell Carter; Saul Harari; Zhiheng Pei
Journal:  Clin Lab Med       Date:  2014-09-15       Impact factor: 1.935

2.  Gut microbiota in multiple sclerosis: possible influence of immunomodulators.

Authors:  Brandi L Cantarel; Emmanuelle Waubant; Christel Chehoud; Justin Kuczynski; Todd Z DeSantis; Janet Warrington; Arun Venkatesan; Claire M Fraser; Ellen M Mowry
Journal:  J Investig Med       Date:  2015-06       Impact factor: 2.895

Review 3.  The role of gut microbiota in the pathogenesis of colorectal cancer.

Authors:  Qingchao Zhu; Renyuan Gao; Wen Wu; Huanlong Qin
Journal:  Tumour Biol       Date:  2013-02-10

Review 4.  Gut microbiota imbalance and colorectal cancer.

Authors:  Johan Gagnière; Jennifer Raisch; Julie Veziant; Nicolas Barnich; Richard Bonnet; Emmanuel Buc; Marie-Agnès Bringer; Denis Pezet; Mathilde Bonnet
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

5.  Drug development for the irritable bowel syndrome: current challenges and future perspectives.

Authors:  Fabrizio De Ponti
Journal:  Front Pharmacol       Date:  2013-02-01       Impact factor: 5.810

6.  Potential probiotic Escherichia coli 16 harboring the Vitreoscilla hemoglobin gene improves gastrointestinal tract colonization and ameliorates carbon tetrachloride induced hepatotoxicity in rats.

Authors:  Prasant Kumar; Ayush V Ranawade; Naresh G Kumar
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.